CSF Author Interview: Dr. David Martin, 2023
The IMID Forum26 Loka 2023

CSF Author Interview: Dr. David Martin, 2023

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr. David Martin, executive medical director at Pfizer in Massachusetts, USA as they discuss his recent paper 'Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors' Detailed summary slides of this paper and many more publications, are free to view and download in the publications section at cytokinesignalling.com.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(423)

Discussing PsA: Difficult-to-manage PsA and molecular and clinical responses to zasocitinib

Discussing PsA: Difficult-to-manage PsA and molecular and clinical responses to zasocitinib

Join Professor Laura Coates and Professor Philip Mease as they discuss recent publications that explored treatment-refractory PsA through real-world EULAR-informed definitions and the longitudinal eff...

15 Loka 17min

Discussing PsA: Difficult-to-manage PsA and molecular/clinical responses to zasocitinib

Discussing PsA: Difficult-to-manage PsA and molecular/clinical responses to zasocitinib

Join Professor Laura Coates and Professor Philip Mease as they discuss recent publications that explored treatment-refractory PsA through real-world EULAR-informed definitions and the longitudinal eff...

15 Loka 17min

Disusisng PsA Sept - Audio only

Disusisng PsA Sept - Audio only

Join Professor Laura Coates and Professor Philip Mease as they discuss recent publications that explored treatment-refractory PsA through real-world EULAR-informed definitions and the longitudinal eff...

15 Loka 17min

Discussing RA: Impact of BMI on response to JAK inhibitors in RA

Discussing RA: Impact of BMI on response to JAK inhibitors in RA

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review paper by Bechman et al. where he highlights the i...

8 Loka 7min

Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials

Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials

Join Dr Sofia Ramiro and Dr Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered whether men and women with axSpA respond differently to bimeki...

30 Syys 20min

Author Interview: Doctor Elise van Mulligen, September 2026

Author Interview: Doctor Elise van Mulligen, September 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor van Mulligen, from the Department of Rheumatology, Leiden University Medical Centre, as they discuss her recent paper ‘Lo...

3 Syys 21min

Discussing RA: Biologic effectiveness and treatment persistence in RA

Discussing RA: Biologic effectiveness and treatment persistence in RA

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Finckh et al. and Charles‑Schoeman et a...

27 Elo 8min

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in PsA. This month’s conversation explores rec...

20 Elo 24min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
aamukahvilla
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
psykologia
rss-duodecim-lehti
rss-rahamania
kesken
rss-liian-kuuma-peruna
rss-uskonto-on-tylsaa
aloita-meditaatio
rss-luonnollinen-synnytys-podcast
adhd-podi
koulu-podcast-2
rss-suomen-aa-podcast
rss-hereilla
rss-arkea-ja-aurinkoa-podcast-espanjasta
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-niinku-asia-on
rss-koira-haudattuna